Cigna Healthcare and MD Anderson Madrid – Hospiten present the guide 'Cancer in the company II' Published on 28/02/2024 The document distinguishes four key moments in the approach to cancer in the company, pre-diagnosis (anticipation, early diagnosis and prevention), diagnosis (impact management), treatment (support) and return to work (readaptation).
MD Anderson Madrid – Hospiten holds an international workshop to discuss the use of HIPEC in advanced ovarian cancer Published on 15/02/2024 The meeting will be attended by the main researchers of the OVHIPEC-1(1) and CHIPOR(2) trials, randomised phase 3 studies assessing the potential efficacy of HIPEC in two specific scenarios of ovarian cancer with peritoneal carcinomatosis.
Radiology plays an integral and fundamental role in managing breast cancer Published on 08/02/2024 Artificial intelligence (AI) contributes to improved diagnosis, faster image analysis and early detection.
MD Anderson Madrid – Hospiten surgeons will use 3D technology to plan their operations Published on 01/02/2024 This technology allows the creation of anatomical models specific to individual patients and assists in surgical planning and the prevention of potential complications.
MD Anderson Madrid – Hospiten introduces the Oncogeriatrics Service to incorporate geriatric care into cancer care Published on 18/01/2024 This technology allows the creation of anatomical models specific to individual patients and assists in surgical planning and the prevention of potential complications.
Fatigue, one of the subjective symptoms most frequently mentioned by cancer patients Published on 10/01/2024 Fatigue affects a high percentage of cancer patients, between 78% and 96%
A healthy Christmas menu adapted to the needs of people with cancer Published on 19/12/2023 Depending on the type of tumour and treatment, it may be important to modify the texture of dishes or control the quantities ingested or volume of liquids, always avoiding saturated fats and refined sugars.
The 1st Scientific Open Day of EL Sabor Perdido (The Lost Flavour) focuses on responding to the loss or alteration in the sense of taste and smell among cancer patients Published on 14/12/2023 The Missing Flavor is a project aimed at addressing one of the major challenges associated with cancer treatments, namely the loss of appetite, sense of smell and bad taste of food, which affects approximately half of patients1
MD Anderson Madrid – Hospiten opens its new Multidisciplinary Retroperitoneal Sarcoma Unit Published on 12/12/2023 The average annual incidence of soft tissue sarcomas is between 3-4 cases per 100,000 population. 15% occur in the retroperitoneum1
A new nutritional study demonstrates the close relation between obesity and prostate cancer Published on 27/11/2023 It has been determined that the average calorific consumption of the patient sample was above 2,200 kcal, compared with the 1,700 kcal average necessary with a diet high in saturated fat and sugars